EPISODE · Feb 27, 2023 · 26 MIN
Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn
from Psychedelic Spotlight Podcast · host Benjamin Lightburn, Sacha Hebbert
Filament Health produces non-synthetic psychedelic substances for research and treatment. They’re known as the first lab to have non-synthesized psilocybin for clinical trials and hope to show the efficacy of naturally derived psychedelics. Benjamin explains some current clinical trials as they test out the difference between oral and sublingual administration of psilocybin.We also dive into the Special Access Program and how to apply to Health Canada for access to non-approved drugs for experimental treatments of depression.You can keep in touch with Benjamin on Twitter (@benlightburn) or with Filament Health on Twitter (@FilamentHealth), Instagram (@FilamentHealth), or on their website (filament.health)
What this episode covers
In this episode, Sacha Hebbert sits with the CEO, Benjamin Lightburn of Filament Health, to discuss the ins and outs of being a licensed dealer of naturally derived psilocybin in Canada and internationally.
NOW PLAYING
Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m